Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

NCT00566345 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3670

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Inactivated seasonal influenza vaccine (split virus, Vero cell-derived)
OTHER: Phosphate buffered saline

Sponsor

Alachua Government Services, Inc.